Ambagon Therapeutics
Developer of small-molecule cancer drugs designed to stabilize the direct interaction of oncogenic proteins. The company's drugs selectively augment the endogenous tumor suppression activity of protei...
Valuation
$0
Share Price
N/A
Total Raised
$108M
Last Round
N/A